{"id":"W2172257129","doi":"10.1016/s0140-6736(05)67566-6","title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","year":2005,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1045,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Infliximab; Psoriasis; Medicine; Psoriasis Area and Severity Index; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Dermatology; Surgery; Randomized controlled trial; Tumor necrosis factor alpha; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002653593,0.001948597,0.006012233,0.0004747943,0.0006376818,0.001376253,0.001554465,0.003034549,0.006478311],"category_scores_gemma":[0.001779892,0.0009305905,0.002536589,0.0005993953,0.001791921,0.001299374,0.0005186867,0.004092809,0.001238412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007976507,"about_ca_system_score_gemma":0.001064891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001152708,"about_ca_topic_score_gemma":0.001633759,"domain_scores_codex":[0.9990879,0.0004238964,0.00006223642,0.0001529033,0.00007913812,0.0001939174],"domain_scores_gemma":[0.9987462,0.0003644363,0.0002520297,0.0001445922,0.00007705142,0.0004156936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986322,0.002124798,0.0002174255,0.0003986011,0.0007140076,0.00002326547,0.00003000817,0.0001118572,0.001553806,0.00005634672,0.000499325,0.007948519],"study_design_scores_gemma":[0.9715256,0.02660758,0.0009506384,0.0000202977,0.0003152492,0.00002306911,0.000009273273,0.0001163933,0.0001226146,0.00004715523,0.0002543981,0.000007685967],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973013,0.01581787,0.001457304,0.001473262,0.00117818,0.003131041,0.001120907,0.0003038133,0.002504713],"genre_scores_gemma":[0.9759945,0.007190987,0.002421216,0.002536448,0.001099431,0.003615471,0.001589372,0.00005338951,0.005499138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006478311,"threshold_uncertainty_score":0.02167213,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06806402176190217,"score_gpt":0.3177268351608078,"score_spread":0.2496628133989056,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}